Skip to main content
Top
Published in: Respiratory Research 1/2012

Open Access 01-12-2012 | Research

Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study

Authors: Toru Oga, Mitsuhiro Tsukino, Takashi Hajiro, Akihiko Ikeda, Koichi Nishimura

Published in: Respiratory Research | Issue 1/2012

Login to get access

Abstract

Background

Guidelines recommend that symptoms as well as lung function should be monitored for the management of patients with chronic obstructive pulmonary disease (COPD). However, limited data are available regarding the longitudinal change in dyspnea, and it remains unknown which of relevant measurements might be used for following dyspnea.

Methods

We previously consecutively recruited 137 male outpatients with moderate to very severe COPD, and followed them every 6 months for 5 years. We then reviewed and reanalyzed the data focusing on the relationships between the change in dyspnea and the changes in other clinical measurements of lung function, exercise tolerance tests and psychological status. Dyspnea with activities of daily living was assessed with the Oxygen Cost Diagram (OCD) and modified Medical Research Council dyspnea scale (mMRC), and two dimensions of disease-specific health status questionnaires of the Chronic Respiratory Disease Questionnaire (CRQ) and the St. George’s Respiratory Questionnaire (SGRQ) were also used. Dyspnea at the end of exercise tolerance tests was measured using the Borg scale.

Results

The mMRC, CRQ dyspnea and SGRQ activity significantly worsened over time (p < 0.001), but the OCD did not (p = 0.097). Multiple regression analyses revealed that the changes in the OCD, mMRC, CRQ dyspnea and SGRQ activity were significantly correlated to changes in forced expiratory volume in one second (FEV1) (correlation of determination (r2) = 0.05-0.19), diffusing capacity for carbon monoxide (r2 = 0.04-0.08) and psychological status evaluated by Hospital Anxiety and Depression Scale (r2 = 0.14-0.17), although these correlations were weak. Peak Borg score decreased rather significantly, but was unrelated to changes in clinical measurements.

Conclusion

Dyspnea worsened over time in patients with COPD. However, as different dyspnea measurements showed different evaluative characteristics, it is important to follow dyspnea using appropriate measurements. Progressive dyspnea was related not only to progressive airflow limitation, but also to various factors such as worsening of diffusing capacity or psychological status. Changes in peak dyspnea at the end of exercise may evaluate different aspects from other dyspnea measurements.
Appendix
Available only for authorised users
Literature
1.
go back to reference Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.com (updated 2011) Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. http://​www.​goldcopd.​com (updated 2011)
2.
3.
go back to reference Mahler DA, Tomlinson D, Olmstead EM, Tosteson ANA, O’Connor GT: Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med. 1995, 151: 61-65.PubMedCrossRef Mahler DA, Tomlinson D, Olmstead EM, Tosteson ANA, O’Connor GT: Changes in dyspnea, health status, and lung function in chronic airway disease. Am J Respir Crit Care Med. 1995, 151: 61-65.PubMedCrossRef
4.
go back to reference Lareau SC, Meek PM, Press D, Anholm JD, Roos PJ: Dyspnea in patients with chronic obstructive pulmonary disease: does dyspnea worsen longitudinally in the presence of declining lung function?. Heart Lung. 1999, 28: 65-73. 10.1016/S0147-9563(99)70044-0.PubMedCrossRef Lareau SC, Meek PM, Press D, Anholm JD, Roos PJ: Dyspnea in patients with chronic obstructive pulmonary disease: does dyspnea worsen longitudinally in the presence of declining lung function?. Heart Lung. 1999, 28: 65-73. 10.1016/S0147-9563(99)70044-0.PubMedCrossRef
5.
go back to reference Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M: Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med. 2007, 101: 146-153. 10.1016/j.rmed.2006.04.001.PubMedCrossRef Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M: Longitudinal deteriorations in patient reported outcomes in patients with COPD. Respir Med. 2007, 101: 146-153. 10.1016/j.rmed.2006.04.001.PubMedCrossRef
6.
go back to reference Glaab T, Vogelmeier C, Buhl R: Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res. 2010, 11: 79-10.1186/1465-9921-11-79.PubMedPubMedCentralCrossRef Glaab T, Vogelmeier C, Buhl R: Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res. 2010, 11: 79-10.1186/1465-9921-11-79.PubMedPubMedCentralCrossRef
7.
go back to reference McGravin CR, Artvinli M, Naoe H: Dyspnoea, disability, and distance walked: comparison of exercise performance in respiratory disease. BMJ. 1978, 2: 241-243. 10.1136/bmj.2.6132.241.CrossRef McGravin CR, Artvinli M, Naoe H: Dyspnoea, disability, and distance walked: comparison of exercise performance in respiratory disease. BMJ. 1978, 2: 241-243. 10.1136/bmj.2.6132.241.CrossRef
8.
go back to reference Brooks SM: Surveillance for respiratory hazards. ATS News. 1982, 8: 12-16. Brooks SM: Surveillance for respiratory hazards. ATS News. 1982, 8: 12-16.
9.
go back to reference Mahler DA, Weinberg DH, Wells CK, Feinstein AR: The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984, 85: 751-758. 10.1378/chest.85.6.751.PubMedCrossRef Mahler DA, Weinberg DH, Wells CK, Feinstein AR: The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984, 85: 751-758. 10.1378/chest.85.6.751.PubMedCrossRef
10.
go back to reference Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42: 773-778. 10.1136/thx.42.10.773.PubMedPubMedCentralCrossRef Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW: A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987, 42: 773-778. 10.1136/thx.42.10.773.PubMedPubMedCentralCrossRef
11.
go back to reference Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation: the St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992, 145: 1321-1327.PubMedCrossRef Jones PW, Quirk FH, Baveystock CM, Littlejohns P: A self-complete measure of health status for chronic airflow limitation: the St. George’s Respiratory Questionnaire. Am Rev Respir Dis. 1992, 145: 1321-1327.PubMedCrossRef
12.
go back to reference Borg GAV: Psychophysical basis of perceived exertion. Med Sci Sports Exerc. 1982, 14: 377-381.PubMed Borg GAV: Psychophysical basis of perceived exertion. Med Sci Sports Exerc. 1982, 14: 377-381.PubMed
13.
go back to reference Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T: Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 158: 1185-1189.PubMedCrossRef Hajiro T, Nishimura K, Tsukino M, Ikeda A, Koyama H, Izumi T: Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998, 158: 1185-1189.PubMedCrossRef
14.
go back to reference Mahler DA: Measurement of dyspnea: clinical ratings. Dyspnea: mechanisms, measurement, and management Vol. 208, 147–165. Edited by: Mahler DA, O’Donnell DE. 2005, Boca Raton, FL: Taylor&Francis Group, SecondCrossRef Mahler DA: Measurement of dyspnea: clinical ratings. Dyspnea: mechanisms, measurement, and management Vol. 208, 147–165. Edited by: Mahler DA, O’Donnell DE. 2005, Boca Raton, FL: Taylor&Francis Group, SecondCrossRef
15.
go back to reference Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M: Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest. 2005, 128: 62-69. 10.1378/chest.128.1.62.PubMedCrossRef Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M: Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years. Chest. 2005, 128: 62-69. 10.1378/chest.128.1.62.PubMedCrossRef
16.
go back to reference Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Izumi T: The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med. 2000, 161: 1897-1901.PubMedCrossRef Oga T, Nishimura K, Tsukino M, Hajiro T, Ikeda A, Izumi T: The effects of oxitropium bromide on exercise performance in patients with stable chronic obstructive pulmonary disease. A comparison of three different exercise tests. Am J Respir Crit Care Med. 2000, 161: 1897-1901.PubMedCrossRef
17.
go back to reference Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.PubMedCrossRef Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983, 67: 361-370. 10.1111/j.1600-0447.1983.tb09716.x.PubMedCrossRef
18.
go back to reference Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M: Analysis of longitudinal changes in the psychological status of patients with asthma. Respir Med. 2007, 101: 2133-2138. 10.1016/j.rmed.2007.05.009.PubMedCrossRef Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Mishima M: Analysis of longitudinal changes in the psychological status of patients with asthma. Respir Med. 2007, 101: 2133-2138. 10.1016/j.rmed.2007.05.009.PubMedCrossRef
19.
go back to reference Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Koyama H, Mishima M: Longitudinal changes in patient vs physician-based outcome measures did not significantly correlate in asthma. J Clin Epidemiol. 2005, 58: 532-539. 10.1016/j.jclinepi.2004.09.012.PubMedCrossRef Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T, Koyama H, Mishima M: Longitudinal changes in patient vs physician-based outcome measures did not significantly correlate in asthma. J Clin Epidemiol. 2005, 58: 532-539. 10.1016/j.jclinepi.2004.09.012.PubMedCrossRef
20.
go back to reference Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI: Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011, 365: 1184-1192. 10.1056/NEJMoa1105482.PubMedCrossRef Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI: Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011, 365: 1184-1192. 10.1056/NEJMoa1105482.PubMedCrossRef
21.
go back to reference Casanova C, de Torres JP, Aguirre-Jaíme A, Pinto-Plata V, Marin JM, Cordoba E, Baz R, Cote C, Celli BR: The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med. 2011, 184: 1015-1021. 10.1164/rccm.201105-0831OC.PubMedCrossRef Casanova C, de Torres JP, Aguirre-Jaíme A, Pinto-Plata V, Marin JM, Cordoba E, Baz R, Cote C, Celli BR: The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort. Am J Respir Crit Care Med. 2011, 184: 1015-1021. 10.1164/rccm.201105-0831OC.PubMedCrossRef
22.
go back to reference Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, Igarashi T, Akiyama Y, Ogura S: Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 185: 44-52. 10.1164/rccm.201106-0992OC.PubMedCrossRef Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, Igarashi T, Akiyama Y, Ogura S: Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 185: 44-52. 10.1164/rccm.201106-0992OC.PubMedCrossRef
23.
go back to reference Nishimura K, Izumi T, Tsukino M, Oga T: Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with chronic obstructive pulmonary disease. Chest. 2002, 121: 1434-1440. 10.1378/chest.121.5.1434.PubMedCrossRef Nishimura K, Izumi T, Tsukino M, Oga T: Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with chronic obstructive pulmonary disease. Chest. 2002, 121: 1434-1440. 10.1378/chest.121.5.1434.PubMedCrossRef
24.
go back to reference Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC: Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest. 2007, 132: 1283-1290. 10.1378/chest.07-0703.PubMedCrossRef Mahler DA, Waterman LA, Ward J, McCusker C, ZuWallack R, Baird JC: Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest. 2007, 132: 1283-1290. 10.1378/chest.07-0703.PubMedCrossRef
25.
go back to reference Schünemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH: Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD. 2005, 2: 81-89. 10.1081/COPD-200050651.PubMedCrossRef Schünemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH: Measurement properties and interpretability of the Chronic Respiratory Disease Questionnaire (CRQ). COPD. 2005, 2: 81-89. 10.1081/COPD-200050651.PubMedCrossRef
26.
go back to reference Jones PW, Quirk FH, Baveystock CM: The St. George’s Respiratory Questionnaire. Respir Med. 1991, 85 (Suppl B): 25-31.PubMedCrossRef Jones PW, Quirk FH, Baveystock CM: The St. George’s Respiratory Questionnaire. Respir Med. 1991, 85 (Suppl B): 25-31.PubMedCrossRef
27.
go back to reference Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J: Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010, 11: 122-PubMedPubMedCentral Agusti A, Calverley PM, Celli B, Coxson HO, Edwards LD, Lomas DA, MacNee W, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Wouters E, Yates JC, Vestbo J: Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010, 11: 122-PubMedPubMedCentral
28.
go back to reference Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G: Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res. 2011, 12: 40-10.1186/1465-9921-12-40.PubMedPubMedCentralCrossRef Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G: Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res. 2011, 12: 40-10.1186/1465-9921-12-40.PubMedPubMedCentralCrossRef
29.
go back to reference Jones PW, Donohue JF, Nedelman J, Pascoe S, Pinault G, Lassen C: Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis. Respir Res. 2011, 12: 161-10.1186/1465-9921-12-161.PubMedPubMedCentralCrossRef Jones PW, Donohue JF, Nedelman J, Pascoe S, Pinault G, Lassen C: Correlating changes in lung function with patient outcomes in chronic obstructive pulmonary disease: a pooled analysis. Respir Res. 2011, 12: 161-10.1186/1465-9921-12-161.PubMedPubMedCentralCrossRef
30.
go back to reference Nishimura K, Yasui M, Nishimura T, Oga T: Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD?. Respir Res. 2011, 12: 135-10.1186/1465-9921-12-135.PubMedPubMedCentralCrossRef Nishimura K, Yasui M, Nishimura T, Oga T: Airflow limitation or static hyperinflation: which is more closely related to dyspnea with activities of daily living in patients with COPD?. Respir Res. 2011, 12: 135-10.1186/1465-9921-12-135.PubMedPubMedCentralCrossRef
31.
go back to reference Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A: Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011, 183: 604-611. 10.1164/rccm.201003-0472OC.PubMedCrossRef Hanania NA, Müllerova H, Locantore NW, Vestbo J, Watkins ML, Wouters EF, Rennard SI, Sharafkhaneh A: Determinants of depression in the ECLIPSE chronic obstructive pulmonary disease cohort. Am J Respir Crit Care Med. 2011, 183: 604-611. 10.1164/rccm.201003-0472OC.PubMedCrossRef
32.
go back to reference Laurin C, Moullec G, Bacon SL, Lavoie KL: Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012, 185: 918-923. 10.1164/rccm.201105-0939PP.PubMedCrossRef Laurin C, Moullec G, Bacon SL, Lavoie KL: Impact of anxiety and depression on chronic obstructive pulmonary disease exacerbation risk. Am J Respir Crit Care Med. 2012, 185: 918-923. 10.1164/rccm.201105-0939PP.PubMedCrossRef
33.
go back to reference Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P: Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007, 167: 60-67. 10.1001/archinte.167.1.60.PubMedCrossRef Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P: Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med. 2007, 167: 60-67. 10.1001/archinte.167.1.60.PubMedCrossRef
34.
go back to reference Spencer S, Calverley PM, Burge PS, Jones PW: Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004, 23: 698-702. 10.1183/09031936.04.00121404.PubMedCrossRef Spencer S, Calverley PM, Burge PS, Jones PW: Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004, 23: 698-702. 10.1183/09031936.04.00121404.PubMedCrossRef
35.
go back to reference Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B: Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 186: 155-161. 10.1164/rccm.201201-0034OC.PubMedCrossRef Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B: Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012, 186: 155-161. 10.1164/rccm.201201-0034OC.PubMedCrossRef
36.
go back to reference Oga T, Nishimura K, Tsukino M, Hajiro T, Mishima M: Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD. Respir Med. 2006, 100: 965-971. 10.1016/j.rmed.2005.10.006.PubMedCrossRef Oga T, Nishimura K, Tsukino M, Hajiro T, Mishima M: Dyspnoea with activities of daily living versus peak dyspnoea during exercise in male patients with COPD. Respir Med. 2006, 100: 965-971. 10.1016/j.rmed.2005.10.006.PubMedCrossRef
37.
go back to reference Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, Yates JC, Anderson JA, Willits LR, Wise RA: Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med. 2011, 183: 317-322. 10.1164/rccm.201004-0665OC.PubMedCrossRef Celli B, Vestbo J, Jenkins CR, Jones PW, Ferguson GT, Calverley PM, Yates JC, Anderson JA, Willits LR, Wise RA: Sex differences in mortality and clinical expressions of patients with chronic obstructive pulmonary disease. The TORCH experience. Am J Respir Crit Care Med. 2011, 183: 317-322. 10.1164/rccm.201004-0665OC.PubMedCrossRef
38.
go back to reference Lopez Varela MV, Montes-de Oca M, Halbert RJ, Muiño A, Perez-Padilla R, Tálamo C, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Menezes AM: Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J. 2010, 36: 1034-1041. 10.1183/09031936.00165409.PubMedCrossRef Lopez Varela MV, Montes-de Oca M, Halbert RJ, Muiño A, Perez-Padilla R, Tálamo C, Jardim JR, Valdivia G, Pertuzé J, Moreno D, Menezes AM: Sex-related differences in COPD in five Latin American cities: the PLATINO study. Eur Respir J. 2010, 36: 1034-1041. 10.1183/09031936.00165409.PubMedCrossRef
39.
go back to reference Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM: Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. Chest. 1998, 113: 619-624. 10.1378/chest.113.3.619.PubMedCrossRef Eakin EG, Resnikoff PM, Prewitt LM, Ries AL, Kaplan RM: Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. Chest. 1998, 113: 619-624. 10.1378/chest.113.3.619.PubMedCrossRef
Metadata
Title
Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study
Authors
Toru Oga
Mitsuhiro Tsukino
Takashi Hajiro
Akihiko Ikeda
Koichi Nishimura
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2012
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/1465-9921-13-85

Other articles of this Issue 1/2012

Respiratory Research 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.